Emerging roles of cysteine cathepsins in disease and their potential as drug targets.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Current pharmaceutical design

• Publication date

  2007-01-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/138161207780162962PMID 17311556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature.

  2006cited by this paper
• Distinct roles for cysteine cathepsin genes in multistage tumorigenesis.

  2006cited by this paper
• Paradoxical roles of the immune system during cancer development

  2006cited by this paper
• Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.

  2006cited by this paper
• Destabilizing Role of Cathepsin S in Murine Atherosclerotic Plaques

  2006cited by this paper
• Inflammation, proteases and cancer.

  2006cited by this paper
• SARS Coronavirus, but Not Human Coronavirus NL63, Utilizes Cathepsin L to Infect ACE2-expressing Cells

  2006cited by this paper
• Calpain inhibition: a therapeutic strategy targeting multiple disease states.

  2006cited by this paper
• Murine Cathepsin F Deficiency Causes Neuronal Lipofuscinosis and Late-Onset Neurological Disease

  2006cited by this paper
• Cathepsin S Controls Angiogenesis and Tumor Growth via Matrix-derived Angiogenic Factors*

  2006cited by this paper
• Cathepsin L Is Involved in Proteolytic Processing of the Hendra Virus Fusion Protein

  2005cited by this paper
• Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.

  2005cited by this paper
• P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K.

  2005cited by this paper
• Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity.

  2005cited by this paper
• Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K.

  2005cited by this paper
• The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recycling

  2005cited by this paper
• Disruption of the Cathepsin K Gene Reduces Atherosclerosis Progression and Induces Plaque Fibrosis but Accelerates Macrophage Foam Cell Formation

  2005cited by this paper
• Soluble cathepsin K: a novel marker for the prediction of nontraumatic fractures?

  2005cited by this paper
• Novel and potent cyclic cyanamide-based cathepsin K inhibitors.

  2005cited by this paper
• Recent developments in cathepsin K inhibitor design.

  2005cited by this paper
• Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

  2005cited by this paper
• Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans

  2005cited by this paper
• Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury.

  2005cited by this paper
• A structural screening approach to ketoamide-based inhibitors of cathepsin K.

  2005cited by this paper
• Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection

  2005cited by this paper
• Differential turnover of cortical and trabecular bone in transgenic mice overexpressing cathepsin K.

  2005cited by this paper
• Cathepsin L is required for endothelial progenitor cell–induced neovascularization

  2005cited by this paper
• Lysosomes and autophagy in cell death control

  2005cited by this paper
• Spontaneous development of synovitis and cartilage degeneration in transgenic mice overexpressing cathepsin K.

  2005cited by this paper
• The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics.

  2005cited by this paper
• Cathepsin L is essential for onset of autoimmune diabetes in NOD mice.

  2005cited by this paper
• Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells.

  2005cited by this paper
• Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.

  2005cited by this paper
• Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells

  2005cited by this paper
• Acyclic cyanamide-based inhibitors of cathepsin K.

  2005cited by this paper
• Cardiorenal consequences of atherosclerosis and statins therapy: from the past to the future.

  2005cited by this paper
• Tumor Necrosis Factor Induces the Loss of Sphingosine Kinase-1 by a Cathepsin B-dependent Mechanism*

  2005cited by this paper
• Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitors.

  2005cited by this paper
• Inflammatory-mediated injury and repair in the traumatically injured spinal cord.

  2005cited by this paper
• Ketoheterocycle-based inhibitors of cathepsin K: a novel entry into the synthesis of peptidic ketoheterocycles.

  2005cited by this paper
• Potent and selective ketoamide-based inhibitors of cysteine protease, cathepsin K.

  2004cited by this paper
• uPARAP/endo180 directs lysosomal delivery and degradation of collagen IV.

  2004cited by this paper
• Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis

  2004cited by this paper
• Early diagnosis of osteoarthritis using cathepsin B sensitive near-infrared fluorescent probes.

  2004cited by this paper
• Comprehensive search for cysteine cathepsins in the human genome

  2004cited by this paper
• Identification of a Potent and Selective Noncovalent Cathepsin S Inhibitor

  2004cited by this paper
• Cysteine cathepsins (proteases)--on the main stage of cancer?

  2004cited by this paper
• Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma.

  2004cited by this paper
• Serum level of cathepsin B and its density in men with prostate cancer as novel markers of disease progression.

  2004cited by this paper
• Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis

  2004cited by this paper
• The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K.

  2004cited by this paper
• Exploration of the P1 SAR of aldehyde cathepsin K inhibitors.

  2004cited by this paper
• TNF-alpha-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent.

  2004cited by this paper
• Characterization of Murine Cathepsin W and Its Role in Cell-mediated Cytotoxicity*

  2004cited by this paper
• Cysteine cathepsins in human cancer

  2004cited by this paper
• Pivotal role of cathepsin K in lung fibrosis.

  2004cited by this paper
• Sensitization to the Lysosomal Cell Death Pathway upon Immortalization and Transformation

  2004cited by this paper
• Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.

  2004cited by this paper
• Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis.

  2004cited by this paper
• Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells.

  2004cited by this paper
• Cathepsin S Supports Acid-independent Infection by Some Reoviruses*

  2004cited by this paper
• Regulation of Collagenase Activities of Human Cathepsins by Glycosaminoglycans*

  2004cited by this paper
• Cathepsin K inhibitor-polymer conjugates: potential drugs for the treatment of osteoporosis and rheumatoid arthritis.

  2004cited by this paper
• Cathepsin B Mediates Caspase-Independent Cell Death Induced by Microtubule Stabilizing Agents in Non-Small Cell Lung Cancer Cells

  2004cited by this paper
• Cathepsin L‐deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy

  2004cited by this paper
• Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K.

  2004cited by this paper
• Papillon-Lefèvre Syndrome: Correlating the Molecular, Cellular, and Clinical Consequences of Cathepsin C/Dipeptidyl Peptidase I Deficiency in Humans1

  2004cited by this paper
• Ketoamide-based inhibitors of cysteine protease, cathepsin K: P3 modifications.

  2004cited by this paper
• A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor.

  2004cited by this paper
• Nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin S.

  2004cited by this paper
• Selective Disruption of Lysosomes in HeLa Cells Triggers Apoptosis Mediated by Cleavage of Bid by Multiple Papain-like Lysosomal Cathepsins*

  2004cited by this paper
• Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis

  2004cited by this paper
• Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1', P1, and/or P3 substitutions.

  2004cited by this paper
• Design of small molecule ketoamide-based inhibitors of cathepsin K.

  2004cited by this paper
• Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice.

  2003cited by this paper
• Differential Regulation of Cathepsin S and Cathepsin L in Interferon γ–treated Macrophages

  2003cited by this paper
• Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro.

  2003cited by this paper
• Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K-investigating P1' substituents.

  2003cited by this paper
• Cathepsin B and H activities and cystatin C concentrations in cerebrospinal fluid from patients with leptomeningeal metastasis.

  2003cited by this paper
• Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis.

  2003cited by this paper
• Lysosomal cysteine proteases (cathepsins): promising drug targets.

  2003cited by this paper
• Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells.

  2003cited by this paper
• SP500263, a novel SERM, blocks osteoclastogenesis in a human bone cell model: role of IL-6 and GM-CSF.

  2003cited by this paper
• Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter

  2003cited by this paper
• Basement membranes: structure, assembly and role in tumour angiogenesis

  2003cited by this paper
• Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis.

  2003cited by this paper
• Deficiency of the Cysteine Protease Cathepsin S Impairs Microvessel Growth

  2003cited by this paper
• Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.

  2003cited by this paper
• Thyroid functions of mouse cathepsins B, K, and L.

  2003cited by this paper
• Role of angiogenesis in tumor growth and metastasis.

  2002cited by this paper
• Interaction of Human Breast Fibroblasts with Collagen I Increases Secretion of Procathepsin B*

  2002cited by this paper
• Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice.

  2002cited by this paper
• Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis.

  2002cited by this paper
• Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer.

  2002cited by this paper
• A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat.

  2002cited by this paper
• Degradation of Extracellular Matrix Protein Tenascin-C by Cathepsin B: An Interaction Involved in the Progression of Gliomas

  2002cited by this paper
• Cathepsin L and Cathepsin B Mediate Reovirus Disassembly in Murine Fibroblast Cells*

  2002cited by this paper
• Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

  2002cited by this paper
• Cathepsin L Regulates CD4+ T Cell Selection Independently of Its Effect on Invariant Chain

  2002cited by this paper
• The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling.

  2002cited by this paper

• Simultaneous detection of multiple cathepsin activities by peptide microarray-based metal-enhanced fluorescence assay

  2026cites this paper
• Stefin B and Cystatin C Deficiency Suppresses Tumor Growth and Alters Tumor Microenvironment in a Breast Cancer Model.

  2026cites this paper
• Cathepsin B in urological tumors: unraveling its role and therapeutic potential

  2025cites this paper
• Targeting cysteine protease B to discover antileishmanial drugs: Directions and advances.

  2025cites this paper
• Causal association of cathepsins and endometriosis: A Mendelian randomization study

  2025cites this paper
• Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth.

  2025cites this paper
• Genetic and biomechanics insights into cathepsins and non-cancerous digestive diseases: A bidirectional two-sample Mendelian randomization study

  2025cites this paper
• Cathepsin K Inhibitors as Potential Drugs for the Treatment of Osteoarthritis

  2025cites this paper
• CCDC41 Drives Oocyte Meiotic Progression by Promoting Rab11a/Rab7‐Positive Vesicle Fusion with Target Membranes

  2025cites this paper
• Extracellular Cathepsin B Is a Potential Therapeutic Target in Hepatocellular Carcinoma

  2025cites this paper
• Identification of Cathepsin H and Metabolic Traits as Potential Biomarkers for Lung Cancer by Mendelian Randomization and Single‐Cell Transcriptomics

  2025cites this paper
• Mendelian randomization analysis to explore the relationship between cathepsins and malignant ovarian tumors

  2024cites this paper
• In silico approaches for better understanding cysteine cathepsin-glycosaminoglycan interactions.

  2024cites this paper
• Cathepsin V is a useful prognostic factor for colorectal cancer.

  2024cites this paper
• Integrated machine learning-based virtual screening and biological evaluation for identification of potential inhibitors against cathepsin K

  2024cites this paper
• Novel selective proline-based peptidomimetics for human cathepsin K inhibition.

  2024cites this paper
• Targeted Sensitization of Glioblastoma Multiforme Using AAAPT Technology

  2023cites this paper
• Cathepsin V drives lung cancer progression by shaping the immunosuppressive environment and adhesion molecules cleavage

  2023cites this paper
• The Significance of Cathepsin B in Mediating Radiation Resistance in Colon Carcinoma Cell Line (Caco-2)

  2023cites this paper
• Insight into crustacean cathepsins: Structure-evolutionary relationships and functional roles in physiological processes.

  2023cites this paper
• Cathepsin H: molecular characteristics and clues to function and mechanism.

  2023cites this paper
• Development of the Fundamentals of a Technology for the Production of Tribolium castaneum Recombinant Cathepsin L in Komagataella kurtzmanii Yeast

  2023cites this paper
• Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2

  2023cites this paper
• Cathepsin L regulates oocyte meiosis and preimplantation embryo development

  2023cites this paper
• Impact of the Recognition Part of Dipeptidyl Nitroalkene Compounds on the Inhibition Mechanism of Cysteine Proteases Cruzain and Cathepsin L

  2023cites this paper
• Half-Sandwich Ruthenium Arene Complexes Bearing Clinically Approved Drugs as Ligands: The Importance of Metal-Drug Synergism in Metallodrug Design.

  2023cites this paper
• The Role of Cysteine Protease Cathepsins B, H, C, and X/Z in Neurodegenerative Diseases and Cancer

  2023cites this paper
• Development in the Inhibition of Dengue Proteases as Drug Targets.

  2023cites this paper
• Dipeptide-Derived Alkynes as Potent and Selective Irreversible Inhibitors of Cysteine Cathepsins

  2023cites this paper
• Cathepsin V: Molecular characteristics and significance in health and disease.

  2022cites this paper
• Characterization of Cysteine Cathepsin Expression in the Central Nervous System of Aged Wild-Type and Cathepsin-Deficient Mice

  2022cites this paper
• Testing Affordable Strategies for the Computational Study of Reactivity in Cysteine Proteases: The Case of SARS-CoV-2 3CL Protease Inhibition

  2022cites this paper
• Cysteine Cathepsins: Structure, Physiological Functions, and the Role in Carcinogenesis

  2022cites this paper
• Lysosomal proteases and their role in signaling pathways

  2022cites this paper
• Triple-FRET multi-purpose fluorescent probe for three-protease detection

  2022cites this paper
• Cysteine cathepsins: A long and winding road towards clinics.

  2022cites this paper
• Cleavage of Occludin by Cigarette Smoke-Elicited Cathepsin S Increases Permeability of Lung Epithelial Cells

  2022cites this paper
• Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells.

  2022cites this paper
• Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer.

  2022cites this paper
• Recombinant Cathepsin L of Tribolium castaneum and Its Potential in the Hydrolysis of Immunogenic Gliadin Peptides

  2022cites this paper
• Targeting Oxidative Stress Markers, Xanthine Oxidase, TNFRSF11A and Cathepsin L in Curcumin-Treated Collagen-Induced Arthritis: A Physiological and COSMO-RS Study

  2022cites this paper
• Cathepsin B p.Gly284Val Variant in Parkinson’s Disease Pathogenesis

  2022cites this paper
• [Cysteine cathepsins: structure, physiological functions and their role in carcinogenesis].

  2021cites this paper
• A triple-targeting delivery system carrying two anticancer agents.

  2021cites this paper
• Novel lysosome-targeted anticancer fluorescent agents used in zebrafish and nude mouse tumour imaging

  2021cites this paper
• Exploring the role of cathepsin in rheumatoid arthritis

  2021cites this paper
• Rational construction of genome-reduced Burkholderiales chassis facilitates efficient heterologous production of natural products from proteobacteria

  2021cites this paper
• Cathepsin C Regulates Cytokine-Induced Apoptosis in β-Cell Model Systems

  2021cites this paper
• Synergistic inhibition effects of tea polyphenols as adjuvant of oxytetracycline on Vibrio parahaemolyticus and enhancement of Vibriosis resistance of Exopalaemon carinicauda

  2021cites this paper
• The Role of Cysteine Peptidases in Hematopoietic Stem Cell Differentiation and Modulation of Immune System Function

  2021cites this paper
• In silico analysis of Naegleria fowleri cathepsin B paralogs: important drug targets.

  2021cites this paper
• Elucidating the dual mode of action of dipeptidyl enoates in the inhibition of rhodesain cysteine proteases.

  2021cites this paper
• Multiple sites on SARS‐CoV‐2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V

  2021cites this paper
• Cystatin-like protein of sweet orange (CsinCPI-2) modulates pre-osteoblast differentiation via β-Catenin involvement

  2021cites this paper
• WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors

  2021cites this paper
• Neutrophil-derived granule cargoes: paving the way for tumor growth and progression

  2021cites this paper
• Insights of 8-hydroxyquinolines: A novel target in medicinal chemistry.

  2021cites this paper
• Fractalkine/CX3CR1 Pathway in Neuropathic Pain: An Update

  2021cites this paper
• A Flickering Light at the End of the Pandemic Tunnel.

  2021cites this paper
• Purification and Characterization of a Novel Thermostable Papain Inhibitor from Moringa oleifera with Antimicrobial and Anticoagulant Properties

  2021cites this paper
• Potential New Treatments for Kawasaki Disease, Its Variations, and Multisystem Inflammatory Syndrome

  2021cites this paper
• Cathepsin Inhibition Modulates Metabolism and Polarization of Tumor-Associated Macrophages

  2020cites this paper
• FLI1 and ERG protein degradation is regulated via Cathepsin B lysosomal pathway in human dermal microvascular endothelial cells

  2020cites this paper
• RNA-seq analysis uncovers effects of ammonia on metabolism, oxidant-antioxidant equilibrium and apoptosis in the red swamp crayfish (Procambarus clarkii)

  2020cites this paper
• Sugarcane cystatin CaneCPI-1 promotes osteogenic differentiation in human dental pulp cells: a new insight into cysteine proteases inhibitors.

  2020cites this paper
• Long-term whole-grain rye and wheat consumption and their associations with selected biomarkers of inflammation, endothelial function, and cardiovascular disease

  2020cites this paper
• The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management

  2020cites this paper
• Study on enhanced serum protein protecting and anti-cathepsin activities of various curcumin formulations containing traditional excipients and bio-enhancers.

  2020cites this paper
• Cathepsin S as a potential therapeutic target for chronic pain

  2020cites this paper
• Cathepsin K: The Action in and Beyond Bone

  2020cites this paper
• A pulsed current electric field alters protein expression creating a wound healing phenotype in human skin cells.

  2020cites this paper
• Iron oxides nanoparticles (IOs) exposed to magnetic field promote expression of osteogenic markers in osteoblasts through integrin alpha-3 (INTa-3) activation, inhibits osteoclasts activity and exerts anti-inflammatory action

  2020cites this paper
• Role of Glycosaminoglycans in Procathepsin B Maturation: Molecular Mechanism Elucidated by a Computational Study

  2020cites this paper
• Quantum mechanics/molecular mechanics studies of the mechanism of cysteine proteases inhibition by dipeptidyl nitroalkenes.

  2020cites this paper
• Liquid biopsies for early cancer detection

  2020cites this paper
• Evaluating QM/MM Free Energy Surfaces for Ranking Cysteine Protease Covalent Inhibitors

  2020cites this paper
• The Role of Cathepsins in the Growth of Primary and Secondary Neoplasia in the Bone

  2020cites this paper
• The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors

  2020cites this paper
• An explanation of the pathogenesis of several autoimmune diseases in immuno‐compromised individuals

  2020cites this paper
• Correction to: Iron oxides nanoparticles (IOs) exposed to magnetic field promote expression of osteogenic markers in osteoblasts through integrin alpha-3 (INTa-3) activation, inhibits osteoclasts activity and exerts anti-inflammatory action

  2020cites this paper
• Mechanistic insights into the inhibition mechanism of cysteine cathepsins by chalcone-based inhibitors—a QM cluster model approach

  2019cites this paper
• Covalent Inhibition in Drug Discovery

  2019cites this paper
• ‘Patchiness’ and basic cancer research: unravelling the proteases

  2019cites this paper
• A New Analytical Method for Determination of Cathepsin L Based on the Surface Plasmon Resonance Imaging Biosensor

  2019cites this paper
• Effect of Silymarin on Cathepsin Activity and Oxidative Stress in TNBS-induced Colitis in Rats

  2019cites this paper
• Examination of Teachers’ Attitude towards Open Performance Appraisal on Pupils’ Academic Achievement in Public Primary Schools in Serengeti District, Tanzania

  2019cites this paper
• Imaging of extracellular cathepsin S activity by a selective near infrared fluorescence substrate-based probe.

  2019cites this paper
• Nano-crystalline cellulose: Preparation, modification and usage as sustained release drug delivery excipient for some non-steroidal anti-inflammatory drugs.

  2019cites this paper
• Nitroxoline: repurposing its antimicrobial to antitumor application.

  2019cites this paper
• Development of Improved Tumor-Residualizing, GRPR-Targeted Agents: Preclinical Comparison of an Endolysosomal Trapping Approach in Agonistic and Antagonistic Constructs

  2019influential citation
• Cigarette smoke induces overexpression of active human cathepsin S in lungs from current smokers with or without COPD.

  2019cites this paper
• Cysteine Cathepsins and Their Extracellular Roles: Shaping the Microenvironment

  2019cites this paper
• Organoruthenated Nitroxoline Derivatives Impair Tumor Cell Invasion through Inhibition of Cathepsin B Activity

  2019cites this paper
• Can Cysteine Protease Cross-class Inhibitors Achieve Selectivity?

  2019cites this paper
• Screening of cathepsin B inhibitors in traditional Chinese medicine by capillary electrophoresis with immobilized enzyme microreactor.

  2019cites this paper
• Proteases facilitate the endosomal escape of porcine epidemic diarrhea virus during entry into host cells

  2019cites this paper
• The multifaceted roles of tumor-associated proteases and harnessing their activity for prodrug activation

  2019cites this paper
• Cysteine cathepsins in extracellular matrix remodeling: Extracellular matrix degradation and beyond.

  2018cites this paper
• TGF-β Regulates Cathepsin Activation during Normal and Pathogenic Development

  2018cites this paper
• A ratiometric fluorescence probe for lysosomal polarity.

  2018cites this paper